Cargando…
Development of CDK inhibitors as cancer therapeutics
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2005
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4233502/ http://dx.doi.org/10.1186/bcr1081 |
| _version_ | 1782344728602214400 |
|---|---|
| author | Lane, D |
| author_facet | Lane, D |
| author_sort | Lane, D |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-4233502 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2005 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-42335022014-11-18 Development of CDK inhibitors as cancer therapeutics Lane, D Breast Cancer Res Oral Presentation BioMed Central 2005 2005-06-17 /pmc/articles/PMC4233502/ http://dx.doi.org/10.1186/bcr1081 Text en |
| spellingShingle | Oral Presentation Lane, D Development of CDK inhibitors as cancer therapeutics |
| title | Development of CDK inhibitors as cancer therapeutics |
| title_full | Development of CDK inhibitors as cancer therapeutics |
| title_fullStr | Development of CDK inhibitors as cancer therapeutics |
| title_full_unstemmed | Development of CDK inhibitors as cancer therapeutics |
| title_short | Development of CDK inhibitors as cancer therapeutics |
| title_sort | development of cdk inhibitors as cancer therapeutics |
| topic | Oral Presentation |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4233502/ http://dx.doi.org/10.1186/bcr1081 |
| work_keys_str_mv | AT laned developmentofcdkinhibitorsascancertherapeutics |